Results 51 to 60 of about 53,039 (206)

Caracterización de lesiones de piel en una institución de salud en Bogotá

Ciencia y Cuidado, 2022
Objetivo: Describir las características de las lesiones de piel que ocurren como evento adverso al cuidado clínico en una institución de salud de IV nivel de complejidad.
Ruth Alexandra Castiblanco-Montañez, Angela María Agudelo-Turriago, Jenny Yasmin Salas-Pérez, Margarita María Pérez-Pérez, Melany Yailyn Guzmán-Ruiz   +4 more
doaj   +1 more source

Eventos adversos em pacientes cirúrgicos: Revisão integrativa

Research, Society and Development, 2021
Objetivo: analisar as evidências científicas acerca dos eventos adversos ocorridos em pacientes cirúrgicos. Método: revisão integrativa de literatura, com coleta de dados de setembro a outubro de 2020, em três bases de dados: Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), Medical Literature Analysis and Retrieval System Online ...
Andressa dos Santos, Natielen Pierobon, Fernanda Aparecida Zarichen, Gabriela Luísa Wibbelt, Ana Paula Moro Bertoni, Camila do Carmo Mota, Luzia Souza Evangelista Pulcini, Silvelly Peres Teixeira, Bruna Eloise Lenhani, Larissa Marcondes, Josemar Batista   +10 more
openaire   +2 more sources

Long‐term use of lokivetmab in dogs with atopic dermatitis

Veterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.
Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper, Yury Zablotski, Ralf S. Mueller   +2 more
wiley   +1 more source

Dilemas éticos frente a la seguridad del paciente. Cuidar es pensar

Aquichan, 2009
Este artículo tiene como objetivo, a través del análisis del evento adverso, resaltar la importancia del acto de cuidado de enfermería en el marco de la prestación ética de los servicios de salud. Para tal fin se revisarán conceptos generales sobre ética,
Ana Isabel Gómez Córdoba, Ángela Fernanda Espinosa   +1 more
doaj  

Prevalencia, tiempo de aparición y tiempo de duración de los efectos adversos del implante subdérmico de etonogestrel

Universidad y Salud
Introducción: El implante subdérmico es una opción altamente efectiva de planificación familiar, identificar los efectos adversos permite conocer el comportamiento epidemiológico de este método.
Daniel Iván Hernández-Ruíz, Jeannet Lugos-Castillo, Liliana Galicia-Rodríguez, Enrique Villarreal-Ríos, Marina María Isela Lescas-Hernández, Laura Alicia Cu-Flores, Jesús Elizarrarás-Rivas   +6 more
doaj   +1 more source

Diseño de listas de chequeo para la aplicación de las guías de buenas practicas de seguridad del paciente [PDF]

, 2016
El presente trabajo hace referencia a el Desarrollo de Listas de Chequeo para la aplicación de las Guías de Buenas Prácticas para la Seguridad el Paciente que desarrolla el Ministerio de Salud y Protección Social, en la búsqueda del desarrollo de una ...
Hincapié Moreno, Catalina, Wilches López, Laura Esther   +1 more
core  

Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study [PDF]

, 2008
FUNDAMENTO: A levosimendana é um novo agente inodilatador que aumenta a contratilidade cardíaca pela sensibilização ao Ca(2+) e induz vasodilatação por meio da ativação dos canais KATP/BKCa.
ALBUQUERQUE, Denilson, BAIMA, Jader, BARRETTO, Antonio Carlos Pereira, BOCCHI, Edimar Alcides, Grupo de Estudos de Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia - Estudo BELIEF, LAGE, Silvia, MOREIRA, Maria da Consolação, RASSI, Salvador, RIBEIRO, Jorge Pinto, VILAS-BOAS, Fábio   +9 more
core   +4 more sources

Applying the Estimand Framework to Non‐Inferiority Trials

Pharmaceutical Statistics, Volume 23, Issue 6, Page 1156-1165, November/December 2024.
ABSTRACT Most published applications of the estimand framework have focused on superiority trials. However, non‐inferiority trials present specific challenges compared to superiority trials. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use notes in their addendum on estimands and sensitivity ...
Helle Lynggaard, Oliver N. Keene, Tobias Mütze, Sunita Rehal   +3 more
wiley   +1 more source

The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis

Arquivos de Neuro-Psiquiatria, 2014
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion.
Yara Dadalti Fragoso, Christian Cardoso Arruda, Walter Oleschko Arruda, Joseph Bruno Bidin Brooks, Alfredo Damasceno, Carlos Augusto de Albuquerque Damasceno, Alessandro Finkelsztejn, Juliana Finkelsztejn, Paulo Diniz da Gama, Maria Cristina Brandão Giacomo, Sidney Gomes, Marcus Vinicius Magno Goncalves, Andre Palma da Cunha Matta, Marilia Manprim de Morais, Enedina Maria Lobato de Oliveira, Yuna Ribeiro, Henry Koiti Sato, Carlos Bernardo Tauil   +17 more
doaj   +1 more source

Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports

Cancer Reports, Volume 7, Issue 10, October 2024.
ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There are several drugs known to have a definite or probable causal association with TMA, and carfilzomib, a ...
Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli   +7 more
wiley   +1 more source